Connection

EDWARD MASON to Microbial Sensitivity Tests

This is a "connection" page, showing publications EDWARD MASON has written about Microbial Sensitivity Tests.
Connection Strength

1.664
  1. In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides. Antimicrob Agents Chemother. 2003 Jan; 47(1):166-9.
    View in: PubMed
    Score: 0.158
  2. Discrepancies between results by E-test and standard microbroth dilution testing of Streptococcus pneumoniae for susceptibility to vancomycin. J Clin Microbiol. 1996 Jun; 34(6):1546-7.
    View in: PubMed
    Score: 0.100
  3. Decreased susceptibilities to Retapamulin, Mupirocin, and Chlorhexidine among Staphylococcus aureus isolates causing skin and soft tissue infections in otherwise healthy children. Antimicrob Agents Chemother. 2014 May; 58(5):2878-83.
    View in: PubMed
    Score: 0.086
  4. Testing of Streptococcus pneumoniae for resistance to penicillin. J Clin Microbiol. 1993 May; 31(5):1246-50.
    View in: PubMed
    Score: 0.081
  5. Staphylococcus aureus infections in pediatric oncology patients: high rates of antimicrobial resistance, antiseptic tolerance and complications. Pediatr Infect Dis J. 2013 Feb; 32(2):124-8.
    View in: PubMed
    Score: 0.079
  6. Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009. J Clin Microbiol. 2011 Jun; 49(6):2097-101.
    View in: PubMed
    Score: 0.070
  7. Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children. Antimicrob Agents Chemother. 2011 May; 55(5):2431-3.
    View in: PubMed
    Score: 0.069
  8. Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children. Pediatrics. 2010 Mar; 125(3):429-36.
    View in: PubMed
    Score: 0.065
  9. Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005. J Clin Microbiol. 2009 Jun; 47(6):1628-30.
    View in: PubMed
    Score: 0.061
  10. Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J. 2007 Jun; 26(6):480-4.
    View in: PubMed
    Score: 0.054
  11. Penicillin resistance and serotypes/serogroups of Streptococcus pneumoniae in nasopharyngeal carrier children younger than 2 years in Lima, Peru. Diagn Microbiol Infect Dis. 2005 May; 52(1):59-64.
    View in: PubMed
    Score: 0.046
  12. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes. Pediatr Infect Dis J. 2003 Jul; 22(7):623-7.
    View in: PubMed
    Score: 0.041
  13. Mechanisms of pneumococcal antibiotic resistance and treatment of pneumococcal infections in 2002. Pediatr Ann. 2002 Apr; 31(4):250-60.
    View in: PubMed
    Score: 0.037
  14. Pneumococcal mastoiditis in children. Pediatrics. 2000 Oct; 106(4):695-9.
    View in: PubMed
    Score: 0.034
  15. Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis. J Antimicrob Chemother. 2000 May; 45(5):623-31.
    View in: PubMed
    Score: 0.033
  16. Molecular Characterization of Staphylococcus aureus Isolates From Children With Periorbital or Orbital Cellulitis. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):205-209.
    View in: PubMed
    Score: 0.029
  17. Osteoarticular Infections Caused by Streptococcus pneumoniae in Children in the Post-Pneumococcal Conjugate Vaccine Era. Pediatr Infect Dis J. 2017 Dec; 36(12):1201-1204.
    View in: PubMed
    Score: 0.028
  18. Impact of Health Care Exposure on Genotypic Antiseptic Tolerance in Staphylococcus aureus Infections in a Pediatric Population. Antimicrob Agents Chemother. 2017 07; 61(7).
    View in: PubMed
    Score: 0.027
  19. Use of ceftizoxime screening for the detection of cephalosporin-resistant pneumococci. Diagn Microbiol Infect Dis. 1997 Mar; 27(3):99-101.
    View in: PubMed
    Score: 0.026
  20. Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era. Transpl Infect Dis. 2017 Feb; 19(1).
    View in: PubMed
    Score: 0.026
  21. Role of Operative or Interventional Radiology-Guided Cultures for Osteomyelitis. Pediatrics. 2016 05; 137(5).
    View in: PubMed
    Score: 0.025
  22. In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1996 Apr; 40(4):1039-40.
    View in: PubMed
    Score: 0.025
  23. Healthcare-associated Staphylococcus aureus Bacteremia in Children: Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on Outcome. Pediatr Infect Dis J. 2016 Mar; 35(3):263-8.
    View in: PubMed
    Score: 0.025
  24. Clinical and Molecular Features of Decreased Chlorhexidine Susceptibility among Nosocomial Staphylococcus aureus Isolates at Texas Children's Hospital. Antimicrob Agents Chemother. 2016 Feb; 60(2):1121-8.
    View in: PubMed
    Score: 0.024
  25. Distribution of Streptococcus pneumoniae resistant to penicillin in the USA and in-vitro susceptibility to selected oral antibiotics. J Antimicrob Chemother. 1995 Dec; 36(6):1043-8.
    View in: PubMed
    Score: 0.024
  26. Penicillin-resistant pneumococci in the United States. Pediatr Infect Dis J. 1995 Nov; 14(11):1017-8.
    View in: PubMed
    Score: 0.024
  27. Antimicrobial susceptibilities of Shigella dysenteriae type 1 isolated in Zimbabwe--implications for the management of dysentery. Cent Afr J Med. 1995 Apr; 41(4):132-7.
    View in: PubMed
    Score: 0.023
  28. Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era. Clin Infect Dis. 2015 May 01; 60(9):1339-45.
    View in: PubMed
    Score: 0.023
  29. Impact of the 13-valent pneumococcal conjugate vaccine on chronic sinusitis associated with Streptococcus pneumoniae in children. Pediatr Infect Dis J. 2014 Oct; 33(10):1033-6.
    View in: PubMed
    Score: 0.022
  30. Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae. J Clin Microbiol. 1994 Feb; 32(2):430-2.
    View in: PubMed
    Score: 0.021
  31. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2013 Mar; 32(3):203-7.
    View in: PubMed
    Score: 0.020
  32. Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob Agents Chemother. 1992 Aug; 36(8):1703-7.
    View in: PubMed
    Score: 0.019
  33. Clinical and molecular epidemiology of Staphylococcus aureus catheter-related bacteremia in children. Pediatr Infect Dis J. 2010 May; 29(5):410-4.
    View in: PubMed
    Score: 0.016
  34. Hospital-acquired Staphylococcus aureus infections at Texas Children's Hospital, 2001-2007. Infect Control Hosp Epidemiol. 2010 Feb; 31(2):183-90.
    View in: PubMed
    Score: 0.016
  35. Serotype 19A is the most common Streptococcus pneumoniae isolate in children with chronic sinusitis. Pediatr Infect Dis J. 2009 Sep; 28(9):766-8.
    View in: PubMed
    Score: 0.016
  36. Penicillin susceptibility of Streptococcus pneumoniae in a private pediatric hospital in Houston, Texas. Antimicrob Agents Chemother. 1989 Jul; 33(7):1111-2.
    View in: PubMed
    Score: 0.015
  37. Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates. Pediatrics. 2008 Jul; 122(1):34-9.
    View in: PubMed
    Score: 0.014
  38. Three-year surveillance of community onset health care-associated staphylococcus aureus infections in children. Pediatr Infect Dis J. 2006 Apr; 25(4):349-53.
    View in: PubMed
    Score: 0.012
  39. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics. 2005 Mar; 115(3):642-8.
    View in: PubMed
    Score: 0.011
  40. Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J. 2005 Mar; 24(3):201-6.
    View in: PubMed
    Score: 0.011
  41. Azithromycin compared with beta-lactam antibiotic treatment failures in pneumococcal infections of children. Pediatr Infect Dis J. 2004 May; 23(5):399-405.
    View in: PubMed
    Score: 0.011
  42. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J. 2003 Jul; 22(7):593-8.
    View in: PubMed
    Score: 0.010
  43. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J. 2002 Oct; 21(10):910-7.
    View in: PubMed
    Score: 0.010
  44. Pneumococcal infections in children after transplantation. Clin Infect Dis. 2001 Jul 01; 33(1):16-21.
    View in: PubMed
    Score: 0.009
  45. In vitro synergy of ampicillin and chloramphenicol against gram-negative bacteria. Pediatr Pharmacol (New York). 1981; 1(4):305-11.
    View in: PubMed
    Score: 0.009
  46. Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997. Pediatr Infect Dis J. 2001 Jan; 20(1):34-9.
    View in: PubMed
    Score: 0.009
  47. Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital. Clin Infect Dis. 2000 Dec; 31(6):1321-30.
    View in: PubMed
    Score: 0.009
  48. In vitro activities of the oxazolidinone compounds linezolid (PNU-100766) and eperzolid (PNU-100592) against middle ear isolates of Streptococcus pneumoniae. Int J Antimicrob Agents. 1999 Jul; 12(2):141-4.
    View in: PubMed
    Score: 0.008
  49. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics. 1998 Dec; 102(6):1369-75.
    View in: PubMed
    Score: 0.007
  50. In vitro antibiotic synergy against Flavobacterium meningosepticum: implications for therapeutic options. Clin Infect Dis. 1998 May; 26(5):1169-76.
    View in: PubMed
    Score: 0.007
  51. Antimicrobial activities of beta-lactam antibiotics and gentamicin against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrob Agents Chemother. 1995 May; 39(5):1166-8.
    View in: PubMed
    Score: 0.006
  52. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J. 1994 Jul; 13(7):585-9.
    View in: PubMed
    Score: 0.005
  53. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins. Antimicrob Agents Chemother. 1994 May; 38(5):918-23.
    View in: PubMed
    Score: 0.005
  54. Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia. Antimicrob Agents Chemother. 1993 Nov; 37(11):2401-6.
    View in: PubMed
    Score: 0.005
  55. Penicillin-resistant Streptococcus pneumoniae strains recovered in Houston: identification and molecular characterization of multiple clones. J Infect Dis. 1993 Apr; 167(4):850-6.
    View in: PubMed
    Score: 0.005
  56. Comparative in-vitro activity of LY146032 and eight other antibiotics against gram-positive bacteria isolated from children. J Antimicrob Chemother. 1987 Aug; 20(2):203-7.
    View in: PubMed
    Score: 0.003
  57. Outcome of heteroresistant Staphylococcus aureus infections in children. J Infect Dis. 1987 Jul; 156(1):205-8.
    View in: PubMed
    Score: 0.003
  58. Disc inhibition zones of rifampin against Haemophilus influenzae type b. Pediatr Infect Dis. 1985 Mar-Apr; 4(2):209-10.
    View in: PubMed
    Score: 0.003
  59. Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations. Rev Infect Dis. 1982 Nov-Dec; 4 Suppl:S597-602.
    View in: PubMed
    Score: 0.002
  60. Antagonism of ampicillin and chloramphenicol for meningeal isolates of group B streptococci. Antimicrob Agents Chemother. 1981 Sep; 20(3):281-5.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.